Latest news with #MEA
News18
2 hours ago
- Politics
- News18
Multi-party delegation of Nepal MPs meets Foreign Secretary Misri in Delhi
Agency: New Delhi, Jul 30 (PTI) A multi-party delegation of MPs from Nepal met Foreign Secretary Vikram Misri here on Wednesday and discussed opportunities for expanding the multi-faceted bilateral partnership, the Ministry of External Affairs (MEA) said. In a post on X, MEA Spokesperson Randhir Jaiswal shared some photos from the meeting. 'Foreign Secretary @VikramMisri interacted with a multiparty delegation of MPs from Nepal today and discussed opportunities for expanding the multifaceted India-Nepal partnership for mutual benefit," he said. The visit by the delegation comes ahead of Nepal Prime Minister K P Sharma Oli's planned visit to India. view comments First Published: July 30, 2025, 19:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Zawya
5 hours ago
- Business
- Zawya
New agreement brings breakthrough dyslipidemia treatment to Saudi Arabia and MEA
JEDDAH – Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing innovative therapies for cardiovascular and metabolic diseases, today announced a strategic licensing and supply agreement. This agreement is poised to address the growing need for effective dyslipidemia management in the region, contributing to better patient outcomes and cardiovascular health. Under this agreement, Jamjoom Pharma gets exclusive rights to commercialize in Saudi Arabia and non-exclusive rights for phased expansion across other MEA markets for Althera's fixed-dose combination of dual-action cholesterol-lowering therapy. The product launch in Saudi Arabia is targeted for 2027, with plans for phased expansion across MEA markets, subject to local regulatory approvals. This collaboration marks a major milestone for both companies: Jamjoom strengthens its cardiovascular portfolio with a globally recognized and clinically effective therapy, while Althera expands its international footprint in a high-growth region. The partnership aims to address the region's growing burden of cardiovascular diseases by increasing access to modern, affordable lipid-lowering treatment, to support patients across MEA. Dr. Tarek Hosni, CEO of Jamjoom Pharma, highlighted that: 'Cardiovascular diseases remain to be a leading health concern in Saudi Arabia and the wider MEA region, and this partnership enables us to provide patients across the MEA region with an innovative, evidence-based solution. Expanding access to effective cholesterol management aligns perfectly with our promise to deliver high-quality, affordable medications that improve lives.' Sanjeev Agarwal, CEO of Althera added " This partnership with Jamjoom Pharma is a pivotal step for Althera, allowing us to extend our reach into the rapidly growing MENA region. We are confident that Jamjoom's deep market understanding and robust capabilities make them the perfect partner to deliver our Rproduct to healthcare providers and patients in Saudi Arabia and across MENA. This collaboration is a testament to our dedication to making innovative and affordable cardiovascular treatments more accessible globally." About Althera: Founded in 2010, Althera focuses on developing, out-licensing, manufacturing and supplying high value branded and select complex generic medicines. Althera pioneers innovative value added combinations fostering benefits throughout the value chain resulting in benefits for our partners, payers, prescribers and patients particularly in heart disease, diabetes and obesity management. Althera is headquartered in Dublin, Ireland. About Jamjoom Pharma 'Jamjoom Pharmaceuticals Factory Company': Jamjoom Pharma is a leading pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products. Headquartered in Saudi Arabia, the company was established back in 2000 and is tirelessly operating to support the Saudi Vision 2030 to reinforce the public healthcare system. With a strong focus on patient-centered care, Jamjoom Pharma serves diverse markets across Middle East & Africa, with a bold ambition for more expansion, providing effective solutions in key therapeutic areas (including ophthalmology, dermatology, cardiometabolic, gastrointestinal, and general medicine). Through its state-of-the-art facilities and established distribution channels across the MEA region and dedication to regulatory excellence, Jamjoom Pharma continues to deliver products that meet the highest standards of safety, efficacy, and quality, improving health outcomes for millions of people.
Times of Oman
13 hours ago
- Health
- Times of Oman
"India's humanitarian support to the people of Syria continues": MEA on medical aid dispatch
New Delhi: India's humanitarian outreach to Syria continued with the delivery of a fresh consignment of critical medical aid, the Ministry of External Affairs said. In a 'X' post on Tuesday, MEA Spokesperson Randhir Jaiswal said, "India's humanitarian support to the people of Syria continues." He informed that India had "handed over a consignment of 5 MT of essential life-saving medicines, including anti-cancer, antibiotics and anti-hypertensives to Syria." The gesture is part of India's ongoing efforts to provide relief and medical assistance to conflict-affected regions and underscores New Delhi's commitment to extend support during humanitarian crises. India's continued commitment to global health support was also demonstrated on July 17, when it sent 300,000 doses of Measles and Rubella vaccines, along with other medical supplies, to Bolivia in response to a worsening outbreak in the country. "India dispatched a consignment of 300,000 doses of Measles & Rubella vaccines along with ancillary supplies to support Bolivia in managing the outbreak of the disease. India stands by its friends in the Global South," Ministry of External Affairs spokesperson Randhir Jaiswal said in a post on X. The shipment arrives at a crucial time as Bolivia has declared a National Health Emergency due to a resurgence of measles cases in several areas. So far, 60 confirmed cases have been reported, according to Xinhua. "After urgently convening the National Strategic Council for Health Emergencies, in response to the measles epidemic that the country is experiencing and the high risk of the disease spreading, we have decided to declare a National Health Emergency with the firm intention of protecting the health and lives of the Bolivian people," Bolivian President Luis Arce Catacora announced on social media, as quoted by Xinhua. The emergency move aims to stop the virus from spreading through mass vaccination efforts and a coordinated response involving local governments, regional bodies, and international organisations.
Time of India
17 hours ago
- Politics
- Time of India
Confusion prevails over Nimisha's death sentence revocation
Kochi: Confusion prevails over the revocation of death sentence of Keralite nurse Nimisha Priya, who is now in Sana'a prison in Yemen on death row for the murder of Yemeni citizen Talal Abdo Mahdi. The office of Sunni leader Kanthapuram A P Aboobacker Musaliyar had on Monday claimed that Nimisha's death sentence was revoked following mediation talks between Yemeni religious scholars and govt officials. However, Talal's brother Abdul Fattah Mahdi rejected the claim on Tuesday. External affairs ministry (MEA) of India too didn't verify reports of death sentence cancellation. Samuel Jerome, who holds the power of attorney for Nimisha's mother Prema Kumari, also denied reports regarding Nimisha's death sentence cancellation. "I personally verified with jail authorities and officials from the public prosecutor's office. It is completely false to claim that the execution was overturned," said Jerome in a social media post. He added that Fattah submitted an official request to govt to proceed with the execution in accordance with Yemeni law. When Kanthapuram's office on Tuesday maintained that an agreement was reached to revoke the death sentence, Fattah asked the office to clarify which party communicated with Talal's family and who contacted the blood heirs. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Emergency Generators in Guatemala City: (Prices May Surprise You) Emergency Generator | Search Ads Search Now Undo "I do not believe that the preacher's (Kanthapuram's) office would issue such statements unless someone provided them with false information that we accepted reconciliation and that the death sentence was cancelled, which is absolutely untrue. The Yemeni constitution and judicial system are based on our just Islamic law. Respecting court rulings issued against the murderer is a duty that must not be neglected. Respecting the blood heirs, acknowledging their suffering and their right to implement God's law is also a duty, as ensuring the execution of rights is one of the most sacred meanings of justice and its deepest implications," says Fattah in a Facebook post. Nimisha, a native of Kollengode in Palakkad, was accused of murdering Talal — with whom she started a health clinic in Sana'a and later reportedly entered into a marriage — in July 2017. A trial court sentenced her to death in 2018, a verdict later upheld by an appeals court. Though her execution was scheduled for July 16, it was postponed.
Time of India
17 hours ago
- Politics
- Time of India
Nimisha case reconciliation claim untrue: Victim's brother
KOCHI: Confusion prevails over revocation of death sentence of Nimisha Priya, the Kerala nurse on death row in Yemen for 2017 murder of a Yemeni citizen, with the victim's brother contesting claims by an eminent cleric that an "agreement" has been reached. Victim Talal Abdo Mahdi's brother, Abdul Fattah Mahdi, rejected the claims by Kerala Sunni cleric Kanthapuram A P Aboobacker Musaliyar in a Facebook post on Tuesday. MEA also didn't confirm the reports. Kanthapuram's office Monday said Nimisha's death sentence was revoked following mediation between Yemeni religious scholars and govt officials. Nimisha's execution was earlier scheduled for July 16 but postponed, purportedly on the intervention of Kanthapuram. In his post, Fattah asked Kanthapuram's office to clarify who communicated with Talal's family and his blood heirs. "I do not believe the preacher's office would issue such statements unless someone provided them false information that we accepted reconciliation, which is absolutely untrue," he wrote.
